Maverick Investing

Cryptocurrency Ethereum hits record high
Feb23

Cryptocurrency Ethereum hits record high

Cryptocurrency Ethereum hits record high, lifted by bitcoin, institutional demand By Gertrude Chavez-Dreyfuss NEW YORK (Reuters) – Ethereum, the second largest cryptocurrency in terms of market capitalization and volume, hit a record high on Thursday, lifted by growing institutional interest in the space, and more than a week after its futures were launched on the Chicago Mercantile Exchange. The virtual currency reached an...

Read More
Bitcoin ETF Roars in Debut With $165 Million of Trading Volume
Feb23

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume (Bloomberg) — North America’s first Bitcoin ETF got off to a stellar start in its debut, with investors exchanging $165 million worth of shares. After a relentless surge in the world’s largest digital currency, the first Bitcoin product that’s officially labeled an exchange-traded fund debuted Thursday in Toronto. It’s worth noting, though, that Europe has several...

Read More

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume   (Bloomberg) — North America’s first Bitcoin ETF got off to a stellar start in its debut, with investors exchanging $165 million worth of shares. After a relentless surge in the world’s largest digital currency, the first Bitcoin product that’s officially labeled an exchange-traded fund debuted Thursday in Toronto. It’s worth noting, though, that Europe has...

Read More
NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™
Feb09

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 If Authorized for Use, ZYESAMI™ Would be First Treatment Specifically for Critically Ill Patients with Respiratory Failure RADNOR, Pa. and GENEVA, Feb. 9, 2021 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings...

Read More
RELIEF AFFIRMS INITIATION OF PHASE 2/3
Feb09

RELIEF AFFIRMS INITIATION OF PHASE 2/3

RELIEF AFFIRMS INITIATION OF PHASE 2/3 TRIAL OF INHALED RLF-100™ (AVIPTADIL; ZYESAMI™) IN SEVERE COVID-19 PATIENTS 08 February 2021 Top-line data from intravenous RLF-100™ phase 2b/3 trial expected to be released this month Geneva, Switzerland, February 08, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company”) affirms that its collaboration partner NeuroRx, Inc. has...

Read More
Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments
Feb08

Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments

Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments Tesla has purchased $1.5 billion of Bitcoin, according to a 10-K filed with the Securities and Exchange Commission (SEC), which was first reported by Crowdfund Insider. The massive Bitcoin investment by the electric vehicle maker prompted the cryptocurrency’s price to jump 7 percent, taking it past $43,000 for the first time in its history. Under the SEC filing,...

Read More
Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM
Jan25

Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM

Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM 1:20 am ET January 21, 2021 (Accesswire) Print GENEVA, SWITZERLAND / ACCESSWIRE / January 21, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19...

Read More
Relief and AdVita Sign Binding to Acquire All Shares of AdVita
Jan25

Relief and AdVita Sign Binding to Acquire All Shares of AdVita

Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Mergers & Acquisitions 20.01.2021 / 07:00 Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil Geneva, Switzerland, and...

Read More
The Party May Just Be Starting For Litecoin
Jan17

The Party May Just Be Starting For Litecoin

The Party May Just Be Starting For Litecoin Chris Markoch Fri, January 15, 2021, 11:25 AM·4 min read Frequently known as the silver to bitcoin’s (CCC:BTC) gold, the time may be right for investors to invest in litecoin (CCC:LTC). One of the oldest altcoins, litecoin has jumped over 85% since Dec. 10. But unlike other times when crypto values have surged, this time may be different. Source: Shutterstock For a brief moment in early...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan17

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year Medical staff examine a patient in the Covid-19 intensive care unit at United Memorial Medical Center in Houston on Nov. 16, 2020. Go Nakamura | Getty Images KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data...

Read More
Market Pulse: VIX Keeps Sliding as the S&P 500 Holds 3800
Jan17

Market Pulse: VIX Keeps Sliding as the S&P 500 Holds 3800

Market Pulse: VIX Keeps Sliding as the S&P 500 Holds 3800   The volatility index has been falling all year, and now may be preparing for a push below the key 20 level. This chart highlights the descending triangle on VIX . It began when the market slumped in late October, with another spike on December 21. There were additional lower highs on January 4 and 12. VIX has also dropped in six of the last seven sessions and has...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan07

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data from its late-stage trial of RLF-100 in January. Relief Therapeutics had a market cap of less than 100 million Swiss francs ($113 million) at the end of July,...

Read More
ETH breaks above $700 to highs not seen since May 2018
Dec28

ETH breaks above $700 to highs not seen since May 2018

ETH breaks above $700 to highs not seen since May 2018   The price of ether (ETH) has jumped above $700 to highs not seen since May 2018. Data from Coinbase shows the price of the world’s second-largest cryptocurrency by market capitalization has increased by nearly 13% over the past 24 hours to $710.31 at the time of this writing.     Early this month, CME Group announced that it will list an ETH futures product...

Read More
Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms
Dec28

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms BY JACOB WATSON ON DECEMBER 20, 2020 Microcapdaily continues to cover the exciting story of Relief Therapeutics Holding SA (SWX: RLF) (OTCQB: RLFTF) that skyrocketed up the charts earlier this year as its covid-19 treatment RLF-100 (aviptadil) continues to show significant potential to treat patients who are already in the Intensive Care Unit...

Read More
Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms
Dec12

Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms

Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms December 08, 2020 07:30 ET | Source: Mydecine Innovations Group Inc. Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP nature-sourced psilocybin DENVER, Dec. 08, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF)...

Read More
Number of ‘Wholecoiners’ Drops
Nov29

Number of ‘Wholecoiners’ Drops

Number of ‘Wholecoiners’ Drops as Whales Dump Bitcoin The number of addresses holding at least one whole Bitcoin dropped yesterday, as traders got nervous. By Will Gottsegen In brief The number of addresses holding at least one whole Bitcoin is down following a sell-off earlier this week. It’s not a huge drop-off; the total number of so-called “wholecoiners” is still over 820,000. Those accounts represent the vast majority of...

Read More
Enrollment of 150 patients in phase 2b/3 trial of RLF-100™
Nov14

Enrollment of 150 patients in phase 2b/3 trial of RLF-100™

NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure – Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported NEWS PROVIDED BY NeuroRx  Nov 13, 2020, 05:00 ET RADNOR, Pa. and GENEVA, Nov. 13, 2020 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF,OTCBB:RLFTF)...

Read More
SolarWindow May Be the Next Generation of Solar
Nov05

SolarWindow May Be the Next Generation of Solar

SolarWindow May Be the Next Generation of Solar A liquid coating that produces electricity and a new executive team are behind WNDW stock By Dana Blankenhorn, InvestorPlace Contributor Oct 15, 2020, 11:07 am EST During the last decade solar power has been produced by expensive, dedicated solar panels, placed on roofs or in fields, and sold as a capital good. During the coming decade solar power will evolve into a consumer product,...

Read More
NeuroRx, Inc. and Relief Therapeutics Holdings AG to continue as planned
Nov05

NeuroRx, Inc. and Relief Therapeutics Holdings AG to continue as planned

RADNOR, Pa. and GENEVA, Nov. 5, 2020 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTCBB:RLFTF) (“Relief”) announced that the independent Data Monitoring Committee (DMC) met yesterday and voted unanimously that NCT 04311697 should continue as planned to its full enrollment of 165 patients. Specifically, the committee identified no safety concerns and viewed the study as capable of...

Read More
RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast
Oct29

RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast

RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast BY PAUL KNAG ON OCTOBER 26, 2020 Relief Therapeutics Holding AG (OTCMKTS: RLFTF) is surging up the charts in recent trading since a recent test of the bottom of its current trading range. Relief Therapeutics is quickly emerging as among the most exciting stories in small caps as its coronavirus therapeutic RLF-100 (aviptadil) gains serious traction. The...

Read More